PZRXQ (PhaseRx) OCF Margin %: 0.00% (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is PhaseRx OCF Margin %?

PhaseRx PZRXQ -99.00% OCF Margin % is 0.00% as of Sep. 2017.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. PhaseRx's Cash Flow from Operations for the three months ended in Sep. 2017 was $-2.57 Mil. PhaseRx's Revenue for the three months ended in Sep. 2017 was $0.00 Mil. Therefore, PhaseRx's OCF Margin % for the quarter that ended in Sep. 2017 was 0.00%.

As of today, PhaseRx's current OCF Yield % is -2,197,200.00%.

The historical rank and industry rank for PhaseRx's OCF Margin % or its related term are showing as below:


PZRXQ's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

PhaseRx OCF Margin % Related Terms

PhaseRx OCF Margin % Historical Data

* Premium members only.

The historical data trend for PhaseRx's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhaseRx OCF Margin % Chart

PhaseRx Annual Data
Trend Dec14 Dec15 Dec16
OCF Margin %
-405.08 -1,594.67 0.00

PhaseRx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PhaseRx OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

PhaseRx's OCF Margin for the fiscal year that ended in Dec. 2016 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-9.811/0
= %

PhaseRx's OCF Margin for the quarter that ended in Sep. 2017 is calculated as

OCF Margin=Cash Flow from Operations (Q: Sep. 2017 )/Revenue (Q: Sep. 2017 )
=-2.572/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
PhaseRx (PZRXQ) has a OCF Margin % of 0.00% as of Sep. 2017. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PhaseRx and its competitors.
Is PhaseRx's OCF Margin % too high?
PhaseRx's current OCF Margin % is 0.00%.
How does PhaseRx's OCF Margin % compare to NSPX and HSTC?
PhaseRx's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on PhaseRx and its competitors. PhaseRx's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhaseRx stock overvalued right now?
PhaseRx (PZRXQ) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For PhaseRx (PZRXQ), the current OCF Margin % is 0.00% as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PhaseRx Business Description

Address 410 West Harrison Street, Suite 300, Seattle, WA, USA, 98119
PhaseRx Inc is a biopharmaceutical company. It is developing a portfolio of products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy, or i-ERT. The approach is enabled by proprietary Hybrid messenger RNA, or mRNA, Technology platform, which allows synthesis of the missing enzyme inside the cell. The product portfolio targets the three urea cycle disorders ornithine transcarbamylase deficiency, or OTCD, argininosuccinate lyase deficiency, or ASL deficiency, and argininosuccinate synthetase deficiency, or ASS1 deficiency.